Abstract
AIM: The aim of this review is to critically assess available evidence that blockade of the actions of NPY at one of the five NPY receptor subtypes represents an attractive new drug discovery target for the development of an appetite suppressant drug.
RESULTS: Blockade of the central actions of NPY using anti-NPY antibodies, antisense oligodeoxynucleotides against NPY and NPY receptor antagonists results in a decrease in food intake in energy-deprived animals. These results appear to show that endogenous NPY plays a role in the control of appetite. The fact that NPY receptors exist as at least five different subtypes raises the possibility that the actions of endogenous NPY on food intake can be adequately dissociated from other effects of the peptide. Current drug discovery has produced a number of highly selective NPY receptor antagonists which have been used to establish the NPY Y1 receptor subtype as the most critical in regulating short-term food intake. However, additional studies are now needed to more clearly define the relative contribution of NPY acting through the NPY Y2 and NPY Y5 receptors in the complex sequence of physiological and behavioral events that underlie the long-term control of appetite.
CONCLUSIONS: Blockade of the NPY receptor may produce appetite-suppressing drugs. However, it is too early to state with certainty whether a single subtype selective drug used alone or a combination of NPY receptor selective antagonists used in combination will be necessary to adequately influence appetite regulation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Levine AS, Morley JE . Neuropeptide Y: a potent inducer of consummatory behavior in rats Peptides 1984 5: 1025–1029.
Stanley BG, Leibowitz SF . Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus Life Sci 1984 24: 2635–2642.
Allen LG, Kalra PS, Crowley WR, Kalra SP . Comparison of the effects of neuropeptide Y and adrenergic transmitters on LH release and food intake in male rats Life Sci 1985 37: 617–623.
Beck B, Stricker-Krongrad A, Nicolas JP, Burlet C . Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long–Evans rats mimics the feeding behaviour of obese Zucker rats Int J Obes Relat Metab Disord 1992 16: 295–302.
Sainsbury A, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B . Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats Diabetes 1997 46: 209–214.
McKibbin PE, Rogers P, Williams G . Increased neuropeptide Y concentrations in the lateral hypothalamic area of the rat after the onset of darkness: possible relevance to the circadian periodicity of feeding behavior Life Sci 1991 48: 2527–2533.
Jhanwar-Uniyal M, Beck B, Burlet C, Leibowitz SF . Diurnal rhythm of neuropeptide Y-like immunoreactivity in the suprachiasmatic, arcuate and paraventricular nuclei and other hypothalamic sites Brain Res 1990 536: 331–334.
Sahu A, Sninsky CA, Kalra SP . Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes Brain Res 1997 755: 339–342.
Boswell T, Dunn IC, Corr SA . Hypothalamic neuropeptide Y mRNA is increased after feed restriction in growing broilers Poultry Sci 1999 78: 1203–1207.
Jones PM, Pierson AM, Williams G, Ghatei MA, Bloom SR . Increased hypothalamic neuropeptide Y messenger RNA levels in two rat models of diabetes Diabetic Med 1992 9: 76–80.
Lambert PD, Wilding JP, Turton MD, Ghatei MA, Bloom SR . Effect of food deprivation and streptozotocin-induced diabetes on hypothalamic neuropeptide Y release as measured by a radioimmunoassay-linked microdialysis procedure Brain Res 1994 656: 135–140.
Jang M, Romsos DR . Neuropeptide Y and corticotropin-releasing hormone concentrations within specific hypothalamic regions of lean but not ob/ob mice respond to food-deprivation and refeeding: 1 J Nutr 1998 128: 2520–2525.
Dryden S, Pickavance L, Frankish HM, Williams G . Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats Brain Res 1995 690: 185–188.
Lambert PD, Wilding JP, al-Dokhayel AA, Bohuon C, Comoy E, Gilbey SG, Bloom SR . A role for neuropeptide Y, dynorphin, and noradrenaline in the central control of food intake after food deprivation Endocrinology 1993 133: 29–32.
Burlet A, Grouzmann E, Musse N, Fernette B, Nicolas JP, Burlet C . The immunological impairment of arcuate neuropeptide Y neurons by ricin A chain produces persistent decrease of food intake and body weight Neuroscience 1995 66: 151–159.
Hulsey MG, Pless CM, White BD, Martin RJ . ICV administration of anti-NPY antisense oligonucleotide: effects on feeding behavior, body weight, peptide content and peptide release Regul Pept 1995 59: 207–214.
Chance WT, Sheriff S, Peng F, Balasubramaniam A . Antagonism of NPY-induced feeding by pretreatment with cyclic AMP response element binding protein antisense oligonucleotide Neuropeptides 2000 34: 167–172.
Chance WT, Tao Z, Sheriff S, Balasubramaniam A . WRYamide, a NPY-based tripeptide that antagonizes feeding in rats Brain Res 1998 803: 39–43.
Danielsa AJ, Chance WT, Grizzle MK, Heyer D, Matthews JE . Food intake inhibition and reduction in body weight gain in rats treated with GI264879A, a non-selective NPY-Y1 receptor antagonist Peptides 2001 22: 483–491.
Ishihara A, Tanaka T, Kanatani A, Fukami T, Ihara M, Fukuroda T . A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats Am J Physiol 1998 274: R1500–1504.
Marin-Bivens CL, Kalra SP, Olster DH . Intraventricular injection of neuropeptide Y antisera curbs weight gain and feeding, and increases the display of sexual behaviors in obese Zucker female rats Regul Pept 1998 75–76: 327–334.
Gehlert DR . Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications Proc Soc Exp Biol Med 1998 218: 7–22.
Weingarten HP . Stimulus control of eating: implications for a two-factor theory of hunger Appetite 1985 6: 387–401.
Harris RB . Role of set-point theory in regulation of body weight FASEB J 1990 4: 3310–3318.
Bray GA . Afferent signals regulating food intake Proc Nutr Soc 2000 59: 373–384.
Hansen BC, Ortmeyer HK . Obesity, diabetes, and aging: lessons from life-time studies in monkeys. In: Guy-Grand B, Aihaud G (eds). Progress in obesity research Libbey: London 1999 525–544.
Berridge KC . Food reward: brain substrates of wanting and liking Neurosci Biobehav Rev 1996 20: 1–25.
Collier G, Johnson DF . The time window of feeding Physiol Behav 1990 48: 771–777.
Waterhouse J, Minors D, Atkinson G, Benton D . Chronobiology and meal times: internal and external factors Br J Nutr 1997 77(Suppl 1): S29–38.
Leibowitz SF, Hoebel BG . Behavioral neuroscience of obesity. In: Bray GA, Bouchard C, James WPT (eds). Handbook of Obesity Marcel Dekker: New York 1997 313–358.
Flatt JP . What do we most need to learn about food intake regulation Obes Res 1998 6: 307–310.
Brown CM, Fletcher PJ, Coscina DV . Neuropeptide Y-induced operant responding for sucrose is not mediated by dopamine Peptides 1998 19: 1667–1673.
Brown CM, Coscina DV, Fletcher PJ . The rewarding properties of neuropeptide Y in perifornical hypothalamus vs. nucleus accumbens Peptides 2000 21: 1279–1287.
Heilig M, McLeod S, Koob GK, Britton KT . Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test Regul Pept 1992 41: 61–69.
Flood JF, Morley JE . Increased food intake by neuropeptide Y is due to an increased motivation to eat Peptides 1991 12: 1329–1332.
Seeley RJ, Benoit SC, Davidson TL . Discriminative cues produced by NPY do not generalize to the interoceptive cues produced by food deprivation Physiol Behav 1995 58: 1237–1241.
Jewett DC, Schaal DW, Cleary J, Thompson T, Levine AS . The discriminative stimulus effects of neuropeptide Y Brain Res 1991 561: 165–168.
Ammar AA, Sederholm F, Saito TR, Scheurink AJ, Johnson AE, Sodersten P . NPY-leptin: opposing effects on appetitive and consummatory ingestive behavior and sexual behavior Am J Physiol Regul Integr Comp Physiol 2000 278: R1627–1633.
Altizer AM, Davidson TL . The effects of NPY and 5-TG on responding to cues for fats and carbohydrates Physiol Behav 1999 65: 685–690.
Woods SC, Figlewicz DP, Madden L, Porte D Jr, Sipols AJ, Seeley RJ . NPY and food intake: discrepancies in the model Regul Pept 1998 75–76: 403–408.
Cabeza De Vaca S, Holiman S, Carr KD . A search for the metabolic signal that sensitizes lateral hypothalmic self-stimulation in food restricted rats Physiol Behav 1998 64: 251–260.
Hagan MM, Moss DE . Effect of peptide YY (PYY) on food associated conflict Physiol Behav 1995 58: 731–735.
Mauri MC, Rudelli R, Somaschini E, Roncoroni L, Papa R, Mantero M, Longhini M . Penati Neurobiological and psychopharmacological basis in the therapy of bulimia and anorexia Prog Neuropsychopharmac Biol Psychiat 1996 20: 207–240.
Pages N, Orosco M, Rouch C, Yao O, Jacquot C, Bohuon C . Refeeding after 72 hour fasting alters neuropeptide Y and monoamines in various cerebral areas in the rat Comp Biochem Physiol Comp Physiol 1993 106: 845–849.
Pages N, Orosco M, Rouch C, Yao O, Jacquot C, Bohuon C . Fasting affects more markedly neuropeptide Y than monoamines in the rat brain Pharmac Biochem Behav 1993 44: 71–75.
Beck B, Jhanwar-Uniyal M, Burlet A, Chapleur-Chateau M, Leibowitz SF, Burlet C . Rapid and localized alterations of neuropeptide Y in discrete hypothalamic nuclei with feeding status Brain Res 1990 528: 245–249.
Widdowson PS, Upton R, Henderson L, Buckingham R, Wilson S, Williams G . Reciprocal regional changes in brain NPY receptor density during dietary restriction and dietary-induced obesity in the rat Brain Res 1997 774: 1–10.
Widdowson PS . Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 ‘feeding’ receptor Brain Res 1997 758: 17–25.
Xin XG, Huang XF . Down-regulated NPY receptor subtype-5 mRNA expression in genetically obese mouse brain Neuroreport 1998 9: 737–741.
Benoit SC, Schwartz MW, Lachey JL, Hagan MM, Rushing PA, Blake KA, Yagaloff KA, Kurylko G, Franco L, Danhoo W, Seeley RJ . A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences J Neurosci 2000 20: 3442–3448.
Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS . Neurons containing hypocretin (orexin) project to multiple neuronal systems J Neurosci 1998 18: 9996–10015.
Vrang N, Tang-Christensen M, Larsen PJ, Kristensen P . Recombinant CART peptide induces c-Fos expression in central areas involved in control of feeding behaviour Brain Res 1999 818: 499–509.
Van Dijk G, Thiele TE, Donahey JC, Campfield LA, Smith FJ, Burn P, Bernstein IL, Woods SC, Seeley RJ . Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain Am J Physiol 1996 271: R1096–1100.
Stanley BG, Chin AS, Leibowitz SF . Feeding and drinking elicited by central injection of neuropeptide Y: evidence for a hypothalamic site(s) of action Brain Res Bull 1985 14: 521–524.
McGregor IS, Menendez JA, Atrens DM . Metabolic effects of neuropeptide Y injected into the sulcal prefrontal cortex Brain Res Bull 1990 24: 363–367.
Hagan MM, Castaneda E, Sumaya IC, Fleming SM, Galloway J, Moss DE . The effect of hypothalamic peptide YY on hippocampal acetylcholine release in vivo: implications for limbic function in binge-eating behavior Brain Res 1998 805: 20–28.
Steinman JL, Gunion MW, Morley JE . Forebrain and hindbrain involvement of neuropeptide Y in ingestive behaviors of rats Pharmac Biochem Behav 1994 47: 207–214.
Cummings SL, Truong BG, Gietzen DW . Neuropeptide Y and somatostatin in the anterior piriform cortex alter intake of amino acid-deficient diets Peptides 1998 19: 527–535.
Li BH, Xu B, Rowland NE, Kalra SP . c-fos expression in the rat brain following central administration of neuropeptide Y and effects of food consumption Brain Res 1994 665: 277–284.
Lambert PD, Phillips PJ, Wilding JP, Bloom SR, Herbert J . c-fos expression in the paraventricular nucleus of the hypothalamus following intracerebroventricular infusions of neuropeptide Y Brain Res 1995 670: 59–65.
Palmiter RD, Erickson JC, Hollopeter G, Baraban SC, Schwartz MW . Life without neuropeptide Y Rec Prog Horm Res 1998 53: 163–199.
Erickson JC, Ahima RS, Hollopeter G, Flier JS, Palmiter RD . Endocrine function of neuropeptide Y knockout mice Regul Pept 1997 70: 199–202.
Hollopeter G, Erickson JC, Seeley RJ, Marsh DJ, Palmiter RD . Response of neuropeptide Y-deficient mice to feeding effectors Regul Pept 1998 75–76: 383–389.
Bannon AW, Seda J, Carmouche M, Francis JM, Norman MH, Karbon B, McCaleb ML . Behavioral characterization of neuropeptide Y knockout mice Brain Res 2000 868: 79–87.
Baraban SC, Hollopeter G, Erickson JC, Schwartzkroin PA, Palmiter RD . Knock-out mice reveal a critical antiepileptic role for neuropeptide Y J Neurosci 1997 89: 8927–8936.
Marsh DJ, Miura GI, Yagaloff KA, Schwartz MW, Barsh GS, Palmiter RD . Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues Brain Res 1999 848: 66–77.
Stanley BG, Magdalin W, Seirafi A, Nguyen MM, Leibowitz SF . Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect Peptides 1992 13: 581–587.
Shibasaki T, Oda T, Imaki T, Ling N, Demura H . Injection of anti-neuropeptide Y gamma-globulin into the hypothalamic paraventricular nucleus decreases food intake in rats Brain Res 1993 601: 313–316.
Borisova EV, Kadar T, Telegdy G . Bimodal effect of neuropeptide Y on feeding, and its antagonism by receptor blocking agents in rats Acta Physiol Hung 1991 78: 301–308.
Dube MG, Kalra PS, Crowley WR, Kalra SP . Evidence of a physiological role for neuropeptide Y in ventromedial hypothalamic lesion-induced hyperphagia Brain Res 1995 690: 275–278.
Dube MG, Xu B, Crowley WR, Kalra PS, Kalra SP . Evidence that neuropeptide Y is a physiological signal for normal food intake Brain Res 1994 646: 341–344.
He B, White BD, Edwards GL, Martin RJ . Neuropeptide Y antibody attenuates 2-deoxy-D-glucose induced feeding in rats Brain Res 1998 781: 348–350.
Walter MJ, Scherrer JF, Flood JF, Morley JE . Effects of localized injections of neuropeptide Y antibody on motor activity and other behaviors Peptides 1994 15: 607–613.
Akabayashi A, Wahlestedt C, Alexander JT, Leibowitz SF . Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion Brain Res Mol Brain Res 1994 21: 55–61.
Kalra PS, Kalra SP . Use of antisense oligodeoxynucleotides to study the physiological functions of neuropeptide Y Methods 2000 22: 249–254.
Agrawal S, Zhao Q, Jiang Z, Oliver C, Giles H, Heath J, Serota D . Toxicologic effects of an oligodeoxynucleotide phosphorothioate and its analogs following intravenous administration in rats Antisense Nucleic Acid Drug Dev 1997 7: 575–584.
Dryden S, Pickavance L, Tidd D, Williams G . The lack of specificity of neuropeptide Y (NPY) antisense oligodeoxynucleotides administered intracerebroventricularly in inhibiting food intake and NPY gene expression in the rat hypothalamus J Endocrinol 1998 157: 169–175.
Kanatani A, Ito J, Ishihara A, Iwaasa H, Fukuroda T, Fukami T, MacNeil DJ, Van der Ploeg LH, Ihara M . NPY-induced feeding involves the action of a Y1-like receptor in rodents Regul Pept 1998 75–76: 409–415.
Widdowson PS, Henderson L, Pickavance L, Buckingham R, Tadayyon M, Arch JR, Williams G . Hypothalamic NPY status during positive energy balance and the effects of the NPY antagonist, BW 1229U91, on the consumption of highly palatable energy-rich diet Peptides 1999 20: 367–372.
Schober DA, Gackenheimer SL, Heiman ML, Gehlert DR . Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors J Pharmac Exp Ther 2000 293: 275–280.
Mollereau C, Gouarderes C, Dumont Y, Kotani M, Detheux M, Doods H, Parmentier M, Quirion R, Zajac JM . Agonists and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226 Br J Pharmac 2001 133: 1–4.
Blomqvist AG, Herzog H . Y-receptor subtypes-how many more? TINS 1997 20: 294–298.
Balasubramaniam A . Neuropeptide Y family of hormones: receptor subtypes and antagonists Peptides 1997 18: 445–457.
Larhammar D . Extraordinary structural diversity of NPYfamily receptors Academic Press: London 1997 88–105.
Glaum SR, Miller RJ, Rhim H, Maclean D, Georgic LM, MacKenzie RG, Grundemar L . Characterisation of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem Br J Pharmac 1997 120: 481–487.
Matsumoto M, Nomura T, Momose K, Ideka Y, Kondou Y, Akiho H, Togami J, Kimura Y, Okada M, Yamaguchi T . Inactivation of a novel neuropeptide Y/Peptide YY receptor gene in primate species J Biol Chem 1996 271: 27217–27220.
Rose PM, Lynch JS, Frazier ST, Fisher SM, Chung W, Battaglino P, Fathi Z, Leibel R, Fernandes P . Molecular genetic analysis of a human neuropeptide Y receptor. The human homolog of the murine Y5 receptor maybe a pseudogene J Biol Chem 1997 272: 3622–3627.
Burkhoff AM, Linemeyer DL, Salon JA . Distribution of a novel hypothalamic neuropeptide Y receptor gene and its absence in rat Mol Brain Res 1998 53: 311–316.
Mullins DE, Guzzi M, Xia L, Parker EM . Pharmacological characterisation of the cloned neuropeptide Y y6 receptor Eur J Pharmac 2000 395: 87–93.
Starbäck P, Lundell I, Fredriksson R, Berglund MM, Yan YL, Wraith A, Söderberg C, Postlethwait JH, Larhammar D . Neuropeptide Y receptor subtype with unique properties cloned in the zebrafish: the zYa receptor Mol Brain Res 1999 70: 242–252.
Ringvall M, Berglund MM, Larhammar D . Multiplicity of neuropeptide Y receptors: cloning of a third distinct subtype in the zebrafish Biochem Biophys Res Commun 1997 241: 749–755.
Arvidsson AK, Wraith A, Jönsson-Rylander AC, Larhammar D . Cloning of neuropeptide Y/peptide YY receptor from the atlantic cod: the Yb receptor Regul Peptides 1998 75–76: 39–43.
Tensen CP, Cox KJA, Burke JF, Leurs R, van der Schors RC, Geraerts WPM, Vreugdenhil E, van Heerikhuizen H . Molecular cloning and characterization of an invertebrate homologue of a neuropeptide Y receptor Euro J Neurosci 1998 10: 3409–3416.
Li XJ, Wu YN, North RA, Fortes M . Cloning, functional expres-sion, and developmental regulation of a neuropeptide Y receptor from Drosophila melanogaster J Biol Chem 1992 267: 9–12.
Herzog H . NPY-Y7 receptor gene International application published under the patent cooperation treaty (PCT). International publication number: WO 00/00606 2000.
Parker RMC, Copeland NG, Eyre HJ, Liu M, Gilbert DJ, Crawford J, Couzens M, Sutherland GR, Jenkins NA, Herzog H . Molecular cloning and characterisation of GPR74 a novel G-protein coupled receptor closest related to the Y-receptor family Mol Brain Res 2000 77: 199–208.
Herzog H, Baumgartner M, Vivero C, Selbie LA, Auer B, Shine J . Genomic organization, localization, and allelic differences in the gene for the human neuropeptide Y Y1 receptor J Biol Chem 1993 268: 6703–6707.
Herzog H, Darby K, Ball H, Hort Y, Beck-Sickinger A, Shine J . Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggests coordinate transcriptional regulation Genomics 1997 41: 315–319.
Lutz CM, Frankel WN, Richards JE, Thompson DA . Neuropeptide Y receptor genes on human chromosome 4q31-q32 Map to conserved linkage groups on mouse chromosomes 3 and 8 Genomics 1997 41: 498–500.
Ball HJ, Shine J, Herzog H . Multiple promoters regulate tissue-specific expression of the human NPY-Y1 receptor gene T J Biol Chem 1995 270: 27272–27276.
Herzog H, Selbie LA, Zee RYL, Morris B, Shine J . Neuropeptide-Y Y1 receptor gene polymorphism: cross-sectional analyses in essential hypertension and obesity Biochem Biophys Res Commun 1993 196: 902–906.
Parker EM, Xia L . Extensive alternative splicing in the 5'-untranslated region of the rat and human neuropeptide Y Y5 receptor genes regulates receptor expression J Neurochem 1999 73: 913–920.
Roche C, Boutin P, Dina C, Gyapay G, Basdevant A, Hager J, Guy-Grand B, Clement K, Froguel P . Genetic studies of neuropeptide Y and neuropeptide Y receptors Y1 and Y5 regions in morbid obesity Diabetologia 1997 40: 671–675.
Rosenkranz K, Hinney A, Ziegler A, von Prittwitz S, Barth N, Roth H, Mayer H, Siegfried W, Lehmkuhl G, Poustka F, Schmidt M, Schäfer H, Remschmidt H, Hebebrand J . Screening for mutations in the neuropeptide Y Y5 receptor gene in cohorts belonging to different weight extremes Int J Obes Relat Metab Disord 1998 22: 157–163.
Jenkinson CP, Cray K, Walder K, Herzog H, Hanson R, Ravussin E . Novel polymorphisms in the neuropeptide-Y Y5 receptor associated with obesity in Pima Indians Int J Obes Relat Metab Disord 2000 24: 580–584.
Lynch DR, Walker MW, Miller RJ, Snyder SH . Neuropeptide Y receptor binding sites in rat brain: differential autoradiographic localizations with 125I-peptide YY and 125I-neuropeptide Y imply receptor heterogeneity J Neuroscienc 1989 9: 2608–2612.
Poston WS Jr, Foreyt JP, Borrell L, Haddock CK . Challenges in obesity management South Med J 1998 91: 710–720.
Durkin MM, Walker MW, Smith KE, Gustafson EL, Gerld C, Branchek TA . Expression of a novel neuropeptide Y receptor subtype involved in food intake: an in situ hybridization study of Y5 mRNA distribution in rat brains Exp Neurol 2000 165: 90–100.
Parker RM, Herzog H . Regional distribution of Y-receptor subtype mRNAs in rat brain Eur J Neurosci 1999 11: 1431–1448.
Dumont Y, Jacques D, St-Pierre J-A, Quirion R . Neuropeptide Y receptor subtypes in the mammalian brain: species differences and status in the human central nervous system. In: Grundemar L & Bloom SR (eds). Neuropeptide Y and drug development Academic Press: London 1997 57–86.
Dumont Y, Jacques D, St-Pierre J-A, Tong Y, Parker R, Herzog H, Quirion R . Neuropeptide Y, peptide YY and pancreatic polypeptide receptor proteins and mRNAs in mammalian brain. In: Quirion R, Björklund A, Hökfelt T (eds). Handbook of chemical neuroanatomy 16: Elsevier: Amsterdam 2000 375–475.
Dumont Y, St-Pierre J-A, Quirion R . Comparative autoradiographic distribution of neuropeptide Y Y1 receptors visualized with the Y1 receptor agonist [125I][Leu31, Pro34] PYY and the non peptide antagonist [3H]BIBP3226 Neuroreport 1996 7: 901–904.
Tong Y, Dumont Y, Shen SH, Quirion R . Comparative developmental profile of the neuropeptide Y Y1 receptor gene and protein in the rat brain Brain Res Mol Brain Res 1997 48: 323–332.
Caberlotto L, Tinner B, Brunneman B, Aagnati L, Fuxe K . On the relationship of neuropeptide Y Y1 receptor-immunoreactive neuronal structure to the neuropetide Y-immunoreactive nerve terminal networks. A double immunolabelling analysis in the rat brain Neuroscience 1998 86: 827–845.
Dumont Y, Fournier A, Quirion R . Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain J Neurosci 1998 18: 5565–5574.
Marsh DJ, Baraban SC, Hollopeter G, Palmiter RD . Role of the Y5 neuropeptide Y receptor in limbic seizures Proc Natl Acad Sci USA 1999 96: 13518–13523.
Thorsell A, Michalkiewicz M, Dumont Y, Quirion R, Caberlotto L, Rimondini R, Mathe AA, Heilig M . Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression Proc Natl Acad Sci USA 2000 97: 12852–12857.
Wyss P, Stricker-Krongrad A, Brunner L, Miller J, Crossthwaite A, Whitebread S, Criscione L . The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes Regul Pept 1998 75–76: 363–371.
Parker EM, Balasubramaniam A, Guzzi M, Mullins DE, Salisbury BG, Sheriff S, Witten MB, Hwa JJ . [D-Trp(34)] neuropeptide Y is a potent and selective neuropeptide Y Y(5) receptor agonist with dramatic effects on food intake Peptides 2000 21: 393–399.
Cabrele C, Langer M, Bader R, Wieland HA, Doods HN, Zerbe O, Beck-Sickinger AG . The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats J Biol Chem 2000 275: 36043–36048.
McCrea K, Wisialowski T, Cabrele C, Church B, Beck-Sickinger A, Kraegen E, Herzog H . 2-36[K4,RYYSA(19-23)]PP a novel Y5-receptor preferring ligand with strong stimulatory effect on food intake Regul Pept 2000 87: 47–58.
Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD . Role of the Y5 receptor in feeding and obesity Nature Med 1998 4: 718–721.
Ho MW, Beck-Sickinger AG, Colmers WF . Neuropeptide Y(5) receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices J Neurophysiol 2000 83: 723–734.
Schaffhauser AO, Stricker-Krongrad A, Brunner L, Cumin F, Gerald C, Whitebread S, Criscione L, Hofbauer KG . Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides Diabetes 1997 46: 1792–1798.
Tang-Christensen M, Kristensen P, Stidsen CE, Brand CL, Larsen PJ . Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y J Endocrinol 1998 159: 307–312.
Flynn MC, Turrin NP, Plata-Salaman CR, Ffrench-Mullen JM . Feeding response to neuropeptide Y-related compounds in rats treated with Y5 receptor antisense or sense phosphothiooligodeoxynucleotide Physiol Behav 1999 66: 881–884.
Patent WO 9962892 to Novartis Pharmaceuticals
Patent WO 9827063 to Banyu Pharmaceuticals
Patent WO 0020376 to Ortho-McNeil Pharmaceuticals
Patent WO 9964394 to Schering Corporation
Patent WO 9835957 to Bayer Corporation
Norman MH, Chen N, Chen Z, Fotsch C, Hale C, Han N, Hurt R, Jenkins T, Kincaid J, Liu L, Lu Y, Moreno O, Santora VJ, Sonnenberg JD, Karbon W . Structure–activity relationships of a series of Pyrrolo[3, 2-d]pyrimidine derivatives and related compounds as neuropeptide Y5 receptor antagonists J Med Chem 2000 43: 4288–4312.
McNally JJ, Youngman MA, Lovenberg TW, Nepomuceno D, Wilson S, Dax SL . N-acylated alpha-(3-pyridylmethyl)-beta-aminotetralin antagoinists of the human neuropeptide Y Y5 receptor Bioorg Med Chem Lett 2000 10: 1641–1643.
Criscione L, Rigollier P, Batzl-Hartmann C, Rueger H, Stricker-Krongrad A, Wyss P, Brunner L, Whitebread S, Yamaguchi Y, Gerald C, Heurich RO, Walker MW, Chiesi M, Schilling W, Hofbauer KG, Levens N . Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor J Clin Invest 1998 102: 2136–2145.
Della Zuana O, Sadlo M, Germain M, Félétou M, Chamorro S, Tisserand F, de Montrion C, Boivin JF, Duhault J, Boutin JA, Levens N . Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade Int J Obes Relat Metab Disord 2000 24: 1–11.
Meguid MM, Fetissov SO, Varma M, Sato T, Zhang L, Laviano A, Rossi-Fanelli F . Hypothalamic dopamine and serotonin in the regulation of food intake Nutrition 2000 16: 843–857.
Zarrindast MR, Oveisi MR . Effects of monoamine receptor antagonists on nicotine-induced hypophagia in the rat Eur J Pharmac 1997 321: 157–162.
Wellman PJ . Norepinephrine and the control of food intake Nutrition 2000 16: 837–842.
Kask A, Vasar E, Heidmets LT, Allikmets L, Wikberg JE . Neuropeptide Y Y(5) receptor antagonist CGP71683A: the effects on food intake and anxiety-related behavior in the rat Eur J Pharmac 2001 414: 215–224.
Pu S, Dhillon H, Moldawer LL, Kalra PS, Kalra SP . Neuropeptide Y counteracts the anorectic and weight reducing effects of ciliary neurotropic factor J Neuroendocrinol 2000 12: 827–832.
Patent Fast-Alert December 24, 1999.
Patent Fast-Alert October 9, 1998.
Kanatani A, Ishihara A, Iwaasa H, Nakamura K, Okamoto O, Hidaka M, Ito J, Fukuroda T, MacNeil DJ, Van der Ploeg LH, Ishii Y, Okabe T, Fukami T, Ihara M . L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist Biochem Biophys Res Commun 2000 272: 169–173.
Kanatani A, Fukami T, Ishihara A, Ishii Y, MacNeil DJ, Van der Ploeg LHT, Ihara K . Anorexigenic effects of orally-active NPY antagonists: participation of Y1 and Y5 receptors in feeding behavior Abstract presented at the 6th International NPY Conference Sydney, Australia April 2001.
Elliott RL, Oliver RM, Hammond M, Patterson TA, She L, Hargrove DM, Martin KA, Maurer TS, Kalvass JC, Morgan BM, DaSilva-Jardine P, Stevenson RW, Mack C, Cassella J . The in vitro and in vivo characterization of 3-{2-[6-(2-tert-butoxyethoxy)-pyridin-3-yl]-1H-imidazol-4-yl}-benzonitrile (I), a potent and selective NPY Y5 antagonist Abstract presented at the 6th International NPY Conference Sydney, Australia April 2001.
Antal-Zimanyi, Ortiz AA, Rassnick S, Hogan JB, Huang Y, Bruce MA, Gillman KW, Poindexter GS . Evidence supporting the role of the Y1, but not the Y5 receptor in food intake in rats Abstract presented at the 6th International NPY Conference Sydney, Australia April 2001.
Haynes AC, Arch JR, Wilson S, McClue S, Buckingham RE . Characterization of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor? Regul Pept 1998 75–76: 355–361.
Soll RM, Dinger MC, Lundell I, Larhammer D, Beck-Sickinger AG . Novel analogues of neuropeptide Y with a preference for the Y1-receptor Eur J Biochem 2001 268: 2828–2837.
Naveilhan P, Hassani H, Canals JM, Ekstrand AJ, Larefalk A, Chhajlani V, Arenas E, Gedda K, Svensson L, Thoren P, Ernfors P . Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor Nature Med 1999 5: 1188–1193.
Broberger C, Landry M, Wong H, Walsh JN, Hokfelt T . Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus Neuroendocrinology 1997 66: 393–408.
Dumont Y, Cadieux A, Doods H, Pheng LH, Abounader R, Hamel E, Jacques D, Regoli D, Quirion R . BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist Br J Pharmac 2000 129: 1075–1088.
Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank R . A receptor subtype involved in neuropeptide-Y-induced food intake Nature 1996 382: 168–171.
Takebayashi Y, Koga H, Togami J, Inui A, Kurihara H, Koshiya K, Furuya T, Tanaka A, Murase K . Design of the Y1-receptor-selective cyclic peptide based on the C-terminal sequence of neuropeptide Y J Pept Res 2000 56: 409–415.
Kanatani A, Mashiko S, Murai N, Sugimoto N, Ito J, Fukuroda T, Fukami T, Morin N, MacNeil DJ, Vand der Ploeg LH, Saga Y, Nishimura S, Ihara M . Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice Endocrinology 2000 141: 1011–1016.
Pedrazzini T, Seydoux J, Kunstner P, Aubert JF, Grouzmann E, Beermann T, Brunner HR . Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor Nature Med 1998 4: 722–726.
Kushi A, Sasai H, Koizumi H, Takeda N, Yokoyama M, Nakamura M . Obesity and mild hyperinsulinemia found in neuropeptide-Y1 receptor-deficient mice Proc Natl Acad Sci USA 1998 95: 15659–15664.
Baskin DG, Figlewicz Lattermann D, Seeley RJ, Woods SC, Porte D Jr, Schwartz MW . Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight Brain Res 1999 848: 114–123.
Heilig M . Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amigdala and paradoxically increases feeding Regul Pept 1995 59: 201–205.
Schaffhauser AO, Whitebread S, Haener R, Hofbauer KG, Stricker-Krongrad A . Neuropeptide Y Y1 receptor antisense oligodeoxynucleotides enhance food intake in energy-deprived rats Regul Pept 1998 75–76: 417–423.
Lopez-Valpuesta FJ, Nyce JW, Myers RD . NPY-Y1 receptor antisense injected centrally in rats caused hyperthermia and feeding Neuropharmac Neurotoxicol 1996 7: 343–368.
Lopez-Valpuesta FJ, Nyce JW, Griffin-Biggs TA, Ice JC, Myers RD . Antisense to NPY-Y1 demonstrates that Y1 receptors in the hypothalamus underlie NPY hypothermia and feeding in rats Proc R Soc Lond B Biol Sci 1996 263: 881–886.
Doods HN, Wieland HA, Engel W, Eberlein W, Willim K-D, Enteroth M, Wienen W, Rudolf K . BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties Regul Pept 1996 65: 71–77.
Rudolf K, Eberlein W, Engel W, Wieland HA, Willim K, Entzeroth M, Wienen W, Beck-Sickinger AG, Doods HN . The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP 3226 Eur J Pharmac 1994 271: R11–13.
Kask A, Rago L, Harro J . Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226 Br J Pharmac 1998 124: 1507–1515.
Kask A, Rägo L, Harro J . Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP 3226: antagonism with diazepam Eur J Pharmac 1996 317: R3–4.
Wieland HA, Engel W, Eberlein W, Rudolf K, Doods HN . Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents Br J Pharmac 1998 125: 549–555.
Kanatani A, Kanno T, Ishihara M, Sakuraba A, Tanaka T, Tsuchiya Y, Mase T, Fukuroda T, Fukami T, Ihara M . The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability Biochem Biophys Res Commun 1999 266: 88–91.
Kanatani A, Hata M, Mashiko S, Ishihara A, Okamoto O, Haga Y, Ohe T, Kanno T, Murai N, Ishii Y, Fukuroda T, Fukami T, Ihara M . A typical Y1 receptor regulates feeding behaviors: effects of a potent and selective Y1 antagonist, J-115814 Mol Pharmac 2001 59: 501–505.
Duhault J, Boulanger M, Chamorro S, Boutin JA, Della Zuana Odile, Douillet E, Fauchere J-L, Feletou M, Germain M, Husson B, Vega Monge A, Renard P, Tisserand F . Food intake regulation in rodents: Y5 or Y1 NPY receptors or both? Can J Physiol Pharmacol 2000 78: 173–185.
Dumont Y, Cadieux A, Doods H, Fournier A, Quiron R . Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIBO3304 (Y1) and CGP71683A (Y5) Can J Physiol Pharmac 2000 78: 116–125.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chamorro, S., Della-Zuana, O., Fauchère, JL. et al. Appetite suppression based on selective inhibition of NPY receptors. Int J Obes 26, 281–298 (2002). https://doi.org/10.1038/sj.ijo.0801948
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801948
Keywords
This article is cited by
-
Structural basis for ligand recognition of the neuropeptide Y Y2 receptor
Nature Communications (2021)
-
Energy Metabolic Profile of Mice after Chronic Activation of Central NPY Y1, Y2, or Y5 Receptors**
Obesity Research (2005)
-
A potent and selective NPY Y5 antagonist reduces food intake but not through blockade of the NPY Y5 receptor
International Journal of Obesity (2004)
-
Agonists for neuropeptide Y receptors Y1 and Y5 stimulate different phases of feeding in guinea pigs
British Journal of Pharmacology (2003)
-
Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague–Dawley rats
International Journal of Obesity (2002)